{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:43:29Z","timestamp":1792899809808,"version":"4.5.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82004023"],"award-info":[{"award-number":["82004023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200713"],"award-info":[{"award-number":["82200713"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","award":["LJKZ0857"],"award-info":[{"award-number":["LJKZ0857"]}],"id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","award":["LZ2020075"],"award-info":[{"award-number":["LZ2020075"]}],"id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.biopha.2022.113992","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T05:25:59Z","timestamp":1668403559000},"page":"113992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Metabolic reprogramming of immune cells in pancreatic cancer progression"],"prefix":"10.1016","volume":"157","author":[{"given":"Hong","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runjuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanna","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113992_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12943-020-01169-7","article-title":"Metabolism of pancreatic cancer: paving the way to better anticancer strategies","volume":"19","author":"Qin","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2022.113992_bib2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00595-020-02028-0","article-title":"Pancreatic cancer treatment: better, but a long way to go","volume":"50","author":"Torphy","year":"2020","journal-title":"Surg. Today"},{"key":"10.1016\/j.biopha.2022.113992_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2022.113992_bib4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.trecan.2018.04.001","article-title":"Immunotherapy and prevention of pancreatic cancer","volume":"4","author":"Morrison","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biopha.2022.113992_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/ijms20184504","article-title":"Chemoresistance in pancreatic cancer","volume":"20","author":"Zeng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113992_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/cancers10060193","article-title":"Emerging therapies and future directions in targeting the tumor stroma and immune system in the treatment of pancreatic adenocarcinoma","volume":"10","author":"Ahn","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2022.113992_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2022.113992_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/ijms20030676","article-title":"Inflammation and pancreatic cancer: focus on metabolism, cytokines, and immunity","volume":"20","author":"Padoan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113992_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00018-019-03278-z","article-title":"The enhancement of glycolysis regulates pancreatic cancer metastasis","volume":"77","author":"Yang","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2022.113992_bib10","series-title":"Heterogeneity of cancer metabolism","first-page":"3","article-title":"Glucose Metabolism in Cancer","author":"Bose","year":"2018"},{"key":"10.1016\/j.biopha.2022.113992_bib11","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","article-title":"Macrophage-based approaches for cancer immunotherapy","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2022.113992_bib12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1084\/jem.20180749","article-title":"Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma","volume":"216","author":"Liu","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2022.113992_bib13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","article-title":"Immunological effects of conventional chemotherapy and targeted anticancer agents","volume":"28","author":"Galluzzi","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2022.113992_bib14","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2012.12.042","article-title":"Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma","volume":"144","author":"Zheng","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.113992_bib15","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","article-title":"Dynamics of the immune reaction to pancreatic cancer from inception to invasion","volume":"67","author":"Clark","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2022.113992_bib16","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2022.113992_bib17","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41590-018-0113-3","article-title":"Regulation of macrophage immunometabolism in atherosclerosis","volume":"19","author":"Koelwyn","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2022.113992_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imm.12910","article-title":"Implications of macrophage polarization in autoimmunity","volume":"154","author":"Funes","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2022.113992_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113992_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fimmu.2019.01462","article-title":"The metabolic signature of macrophage responses","volume":"10","author":"Viola","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113992_bib21","first-page":"9","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Chen","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113992_bib22","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.21873\/anticanres.13416","article-title":"RAW 264.7 macrophage polarization by pancreatic cancer cells - a model for studying tumour-promoting macrophages","volume":"39","author":"Khabipov","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2022.113992_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biomaterials.2020.120546","article-title":"Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment","volume":"268","author":"Zhou","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2022.113992_bib24","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-17-3841","article-title":"Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN\/PI3K gamma to promote pancreatic cancer metastasis","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2022.113992_bib25","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.cmet.2019.02.001","article-title":"Macrophage-Released pyrimidines inhibit gemcitabine therapy in pancreatic cancer","volume":"29","author":"Halbrook","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.113992_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/imr.12603","article-title":"Metabolic regulation of macrophage phenotype and function","volume":"280","author":"Saha","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2022.113992_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41577-019-0124-9","article-title":"Immunometabolism at the interface between macrophages and pathogens","volume":"19","author":"Russell","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2022.113992_bib28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.tcb.2020.09.006","article-title":"Lipid metabolism in regulation of macrophage functions","volume":"30","author":"Yan","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.biopha.2022.113992_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11912-018-0699-5","article-title":"Pancreatic cancer metabolism: molecular mechanisms and clinical applications","volume":"20","author":"Hosein","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.biopha.2022.113992_bib30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00262-005-0079-5","article-title":"Surgical influence of pancreatectomy on the function and count of circulating dendritic cells in patients with pancreatic cancer","volume":"55","author":"Takahashi","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.biopha.2022.113992_bib31","series-title":"Immunobiology of dendritic cells","first-page":"1","article-title":"Dendritic cell subsets and locations","author":"Balan","year":"2019"},{"key":"10.1016\/j.biopha.2022.113992_bib32","series-title":"Immunotherapy of cancer","first-page":"195","article-title":"Immunometabolism: A New Target for Improving Cancer Immunotherapy","author":"Guo","year":"2019"},{"key":"10.1016\/j.biopha.2022.113992_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fimmu.2021.613492","article-title":"Metabolism of dendritic cells in tumor microenvironment: for immunotherapy","volume":"12","author":"Peng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113992_bib34","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2005-05-1795","article-title":"Tumor-derived lactic acid modulates dendritic cell activation and antigen expression","volume":"107","author":"Gottfried","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2022.113992_bib35","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.4049\/jimmunol.1302801","article-title":"Oxidized lipids block antigen cross-presentation by dendritic cells in cancer","volume":"192","author":"Cao","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113992_bib36","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2022.113992_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/ijms21197307","article-title":"The immune microenvironment in pancreatic cancer","volume":"21","author":"Huber","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113992_bib38","first-page":"16","article-title":"T lymphocytes: a promising immunotherapeutic target for pancreatitis and pancreatic cancer?","volume":"10","author":"Zhou","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2022.113992_bib39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/cyto.a.23724","article-title":"Comprehensive phenotyping of T cells using flow cytometry","volume":"95A","author":"Mousset","year":"2019","journal-title":"Cytom. Part A"},{"key":"10.1016\/j.biopha.2022.113992_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.canlet.2016.09.003","article-title":"T-cell immunometabolism against cancer","volume":"382","author":"Jiang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2022.113992_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1084\/jem.20200388","article-title":"Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer","volume":"217","author":"Recouvreux","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2022.113992_bib42","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ni.2556","article-title":"Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation","volume":"14","author":"Sinclair","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2022.113992_bib43","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.immuni.2014.04.007","article-title":"Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation","volume":"40","author":"Nakaya","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.113992_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1084\/jem.20191920","article-title":"Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8(+) T cells","volume":"217","author":"Manzo","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2022.113992_bib45","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: Markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.113992_bib46","first-page":"16","article-title":"MDSCs: key criminals of tumor pre-metastatic niche formation","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113992_bib47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","article-title":"Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression","volume":"120","author":"Groth","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2022.113992_bib48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijms21197356","article-title":"Connections between metabolism and epigenetic modification in MDSCs","volume":"21","author":"Dai","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113992_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41416-019-0644-x","article-title":"Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells","volume":"122","author":"Hu","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2022.113992_bib50","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1158\/2326-6066.CIR-20-0111","article-title":"Lactate-Modulated immunosuppression of myeloid-derived suppressor cells contributes to the radioresistance of pancreatic cancer","volume":"8","author":"Yang","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biopha.2022.113992_bib51","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1172\/JCI131859","article-title":"Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells","volume":"130","author":"Oh","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2022.113992_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41467-021-23731-7","article-title":"Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade","volume":"12","author":"Nielsen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.113992_bib53","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1152\/physrev.00012.2018","article-title":"The Neutrophil's role during health and disease","volume":"99","author":"Liew","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2022.113992_bib54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.it.2019.04.012","article-title":"Neutrophil diversity in health and disease","volume":"40","author":"Silvestre-Roig","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2022.113992_bib55","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1111\/jcmm.16555","article-title":"Neutrophil extracellular DNA traps promote pancreatic cancer cells migration and invasion by activating EGFR\/ERK pathway","volume":"25","author":"Jin","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2022.113992_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.10.015","article-title":"Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis","volume":"497","author":"Kajioka","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2022.113992_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/cancers13174495","article-title":"Neutrophil Extracellular Traps (NETs) in cancer invasion, evasion and metastasis","volume":"13","author":"Demkow","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2022.113992_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fimmu.2019.02099","article-title":"Metabolic insight of neutrophils in health and disease","volume":"10","author":"Kumar","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113992_bib59","doi-asserted-by":"crossref","first-page":"629","DOI":"10.33594\/000000245","article-title":"The critical role of cell metabolism for essential Neutrophil functions","volume":"54","author":"Curi","year":"2020","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113992_bib60","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.trecan.2021.04.007","article-title":"Metabolic plasticity of neutrophils: relevance to pathogen responses and cancer","volume":"7","author":"Rogers","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biopha.2022.113992_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41467-018-07505-2","article-title":"Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression","volume":"9","author":"Rice","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.113992_bib62","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/2162402X.2020.1794359","article-title":"B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma","volume":"9","author":"Minici","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2022.113992_bib63","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.trecan.2017.12.006","article-title":"B-Cell metabolic remodeling and cancer","volume":"4","author":"Franchina","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biopha.2022.113992_bib64","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.ccell.2021.09.007","article-title":"B cells and cancer","volume":"39","author":"Engelhard","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2022.113992_bib65","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jmb.2020.10.019","article-title":"Regulatory B cells and T cell Regulation in Cancer","volume":"433","author":"Horii","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.biopha.2022.113992_bib66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1155\/2014\/215471","article-title":"The Roles of Regulatory B Cells in Cancer","volume":"2014","author":"He","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.biopha.2022.113992_bib67","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.4049\/jimmunol.1302062","article-title":"Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-Exposed B cells","volume":"192","author":"Caro-Maldonado","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113992_bib68","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.immuni.2015.09.001","article-title":"Metabolic reprogramming of immune cells in cancer progression","volume":"43","author":"Biswas","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.113992_bib69","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-18-2738","article-title":"AKT as a therapeutic target for cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2022.113992_bib70","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR signaling in cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2022.113992_bib71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13046-019-1470-y","article-title":"Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K\/Akt signaling pathway","volume":"38","author":"Xu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2022.113992_bib72","first-page":"783","article-title":"PI3K\/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia","volume":"19","author":"Xie","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2022.113992_bib73","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.immuni.2021.04.008","article-title":"Glycolytic ATP fuels phosphoinositide 3-kinase signaling to support effector T helper 17 cell responses","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.113992_bib74","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.abb2683","article-title":"Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity","volume":"371","author":"Xu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.113992_bib75","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.molcel.2019.08.006","article-title":"PTEN suppresses glycolysis by dephosphorylating and inhibiting autophosphorylated PGK1","volume":"76","author":"Qian","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2022.113992_bib76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41467-020-15819-3","article-title":"TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K\/AKT pathway and PPP metabolism","volume":"11","author":"Cheng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.113992_bib77","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.113992_bib78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13045-019-0754-1","article-title":"Targeting mTOR for cancer therapy","volume":"12","author":"Hua","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2022.113992_bib79","first-page":"39","article-title":"Regulation of Immune Responses by mTOR,","volume":"30","author":"Powell","year":"2012"},{"key":"10.1016\/j.biopha.2022.113992_bib80","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1038\/ncomms3834","article-title":"The TSC-mTOR pathway regulates macrophage polarization","volume":"4","author":"Byles","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.113992_bib81","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s12094-020-02365-z","article-title":"FAM83H overexpression predicts worse prognosis and correlates with less CD8(+) T cells infiltration and Ras-PI3K-Akt-mTOR signaling pathway in pancreatic cancer","volume":"22","author":"Zhuang","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.biopha.2022.113992_bib82","first-page":"52","article-title":"PD\/PDmm1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K\/Akt\/mTOR signalling pathway","author":"Zhao","year":"2019","journal-title":"Cell Prolif."},{"key":"10.1016\/j.biopha.2022.113992_bib83","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yexcr.2021.112575","article-title":"PD-L1 induces macrophage polarization toward the M2 phenotype via Erk\/Akt\/mTOR","volume":"402","author":"Wei","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2022.113992_bib84","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41422-019-0157-4","article-title":"LKB1 orchestrates dendritic cell metabolic quiescence and anti-tumor immunity","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2022.113992_bib85","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40425-019-0719-5","article-title":"Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8(+) T cells","volume":"7","author":"Mastelic-Gavillet","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biopha.2022.113992_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imbio.2015.06.019","article-title":"Hyaluronan carried by tumor-derived microvesicles induces IL-10 production in classical (CD14(++)CD16(-)) monocytes via PI3K\/Akt\/mTOR-dependent signalling pathway","volume":"222","author":"Lenart","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.biopha.2022.113992_bib87","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","article-title":"AMPK signalling in health and disease","volume":"45","author":"Carling","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.biopha.2022.113992_bib88","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2022.113992_bib89","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1248\/bpb.b17-00724","article-title":"AMPK-Mediated regulation of lipid metabolism by phosphorylation","volume":"41","author":"Wang","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2022.113992_bib90","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-020-01579-x","article-title":"CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling","volume":"39","author":"Gao","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2022.113992_bib91","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/s41388-018-0556-x","article-title":"Targeting surface nucleolin induces autophagy-dependent cell death in pancreatic cancer via AMPK activation","volume":"38","author":"Xu","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2022.113992_bib92","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/gutjnl-2018-316451","article-title":"Stromal biology and therapy in pancreatic cancer: ready for clinical translation?","volume":"68","author":"Neesse","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2022.113992_bib93","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/jcb.22214","article-title":"Role of hypoxia in the hallmarks of human cancer","volume":"107","author":"Ruan","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2022.113992_bib94","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.113992_bib95","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","article-title":"HIF transcription factors, inflammation, and immunity","volume":"41","author":"Palazon","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.113992_bib96","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/med.21771","article-title":"The role of hypoxia-inducible factor 1 in tumor immune evasion","volume":"41","author":"You","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2022.113992_bib97","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41419-021-04469-y","article-title":"Reciprocal regulation of LOXL2 and HIF1 alpha drives the Warburg effect to support pancreatic cancer aggressiveness","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.113992_bib98","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1080\/15476286.2019.1649585","article-title":"Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977\/miR-153 axis","volume":"16","author":"Ou","year":"2019","journal-title":"RNA Biol."},{"key":"10.1016\/j.biopha.2022.113992_bib99","series-title":"Myc\/Max\/Mad transcription factor network","first-page":"169","article-title":"c-Myc, Genome Instability, and Tumorigenesis: the Devil Is in the Details","author":"Wade","year":"2006"},{"key":"10.1016\/j.biopha.2022.113992_bib100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12964-019-0344-4","article-title":"PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7\/cMyc axis","volume":"17","author":"Qin","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.biopha.2022.113992_bib101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cpr.12603","article-title":"Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK\/cMyc axis in pancreatic cancer","volume":"52","author":"Qin","year":"2019","journal-title":"Cell Prolif."},{"key":"10.1016\/j.biopha.2022.113992_bib102","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/cells8060575","article-title":"CD28 autonomous signaling up-regulates C-Myc expression and promotes glycolysis enabling inflammatory T cell responses in multiple sclerosis","volume":"8","author":"Kunkl","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2022.113992_bib103","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/cdd.2014.212","article-title":"A unique role for p53 in the regulation of M2 macrophage polarization","volume":"22","author":"Li","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2022.113992_bib104","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1158\/2326-6066.CIR-20-0085","article-title":"Immunosuppressive myeloid cells induce nitric oxide-dependent DNA damage and p53 pathway activation in CD8(+) T cells","volume":"9","author":"Cartwright","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biopha.2022.113992_bib105","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/onc.2016.502","article-title":"Census and evaluation of p53 target genes","volume":"36","author":"Fischer","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2022.113992_bib106","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.molcel.2011.08.038","article-title":"ROS-Mediated p53 Induction of Lpin1 Regulates Fatty Acid Oxidation in Response to Nutritional Stress","volume":"44","author":"Assaily","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2022.113992_bib107","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.canlet.2013.12.025","article-title":"Tumor suppressor p53 and its mutants in cancer metabolism","volume":"356","author":"Liu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2022.113992_bib108","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopha.2022.113063","article-title":"Pimozide inhibits the growth of breast cancer cells by alleviating the Warburg effect through the P53 signaling pathway","volume":"150","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113992_bib109","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.bbalip.2016.01.019","article-title":"PPAR beta\/delta and lipid metabolism in the heart","volume":"1861","author":"Palomer","year":"2016","journal-title":"Biochim. Et. Biophys. Acta-Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.biopha.2022.113992_bib110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/biom12081031","article-title":"Dostarlimab: a review","volume":"12","author":"Costa","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2022.113992_bib111","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1158\/1078-0432.CCR-18-2740","article-title":"Phase I study of the indoleamine 2,3-Dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) administered with PD-L1 inhibitor (Atezolizumab) in advanced solid tumors","volume":"25","author":"Jung","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2022.113992_bib112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semcancer.2018.09.008","article-title":"Metabolism and epigenetics of pancreatic cancer stem cells","volume":"57","author":"Lanfranca","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biopha.2022.113992_bib113","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1533033820962117","article-title":"Pancreatic cancer: a review of risk factors, diagnosis, and treatment","volume":"19","author":"Zhao","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2022.113992_bib114","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/nu12061543","article-title":"Pancreatic cancer and cachexia-metabolic mechanisms and novel insights","volume":"12","author":"Poulia","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2022.113992_bib115","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2022.113992_bib116","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1158\/0008-5472.CAN-08-0360","article-title":"Altered detoxification status and increased resistance to oxidative stress by K-Ras transformation","volume":"68","author":"Recktenwald","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2022.113992_bib117","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40360-019-0301-2","article-title":"Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells","volume":"20","author":"Korga","year":"2019","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2022.113992_bib118","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.113992_bib119","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.cell.2018.10.001","article-title":"Distinct regulation of Th17 and Th1 Cell differentiation by glutaminase-dependent metabolism","volume":"175","author":"Johnson","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.113992_bib120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment","volume":"5","author":"Steggerda","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biopha.2022.113992_bib121","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222013816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222013816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:13:02Z","timestamp":1778242382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222013816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":121,"alternative-id":["S0753332222013816"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113992","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming of immune cells in pancreatic cancer progression","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113992"}}